Best US healthcare stocks
Updated November 15, 2026
We cover 971 US-listed healthcare stocks. The largest is ELI LILLY & Co (LLY), worth $1.36T. The table shows the 20 with the highest analysis scores.
| # | Company | Market cap | Upside to fair value | Dividend | Score |
|---|---|---|---|---|---|
| 1 | Exelixis, Inc.EXEL | $16.8B | +14% | — | 4.4 |
| 2 | Resmed Inc.RMD | $33.7B | -28% | 1.1% | 4.2 |
| 3 | UNITED THERAPEUTICS CorpUTHR | $25.2B | -45% | — | 4.0 |
| 4 | Universal Health Services Inc.UHS | $11.2B | +67% | 0.4% | 3.8 |
| 5 | Encompass Health CorpEHC | $13.8B | -47% | 0.6% | 3.6 |
| 6 | ELI LILLY & CoLLY | $1.36T | -37% | 0.5% | 3.4 |
| 7 | Novo Nordisk A SNVO | $184.3B | -37% | 4.3% | 3.4 |
| 8 | Cardinal Health Inc.CAH | $65.0B | +16% | 0.7% | 3.4 |
| 9 | IDEXX Laboratories Inc. /deIDXX | $55.5B | -63% | — | 3.4 |
| 10 | Zoetis Inc.ZTS | $34.1B | -21% | 2.6% | 3.4 |
| 11 | DexCom Inc.DXCM | $31.1B | -41% | — | 3.4 |
| 12 | Halozyme Therapeutics, Inc.HALO | $11.4B | +199% | — | 3.4 |
| 13 | Intuitive Surgical Inc.ISRG | $153.8B | -60% | — | 3.2 |
| 14 | Regeneron Pharmaceuticals, Inc.REGN | $98.8B | +17% | 0.4% | 3.2 |
| 15 | Cigna GroupCI | $78.3B | +98% | 2.1% | 3.2 |
| 16 | Cencora, Inc.COR | $68.5B | -14% | 0.8% | 3.2 |
| 17 | Medpace Holdings, Inc.MEDP | $18.3B | -32% | — | 3.2 |
| 18 | UnitedHealth Group Inc.UNH | $365.1B | +1% | 2.3% | 3.0 |
| 19 | Mckesson Corp.MCK | $127.3B | -4% | 0.4% | 3.0 |
| 20 | HCA Healthcare, Inc.HCA | $104.2B | +3% | 0.6% | 3.0 |
A closer look at the top three
Exelixis, Inc. (EXEL): It has revenue growth of 13% a year over three years, an average net margin of 23%, a P/E of about 21, an intrinsic value about 14% above the current price and an overall score of 4.4 out of 5 (strong company).
Resmed Inc. (RMD): It has revenue growth of 10% a year over three years, an average net margin of 25%, a P/E of about 22, an intrinsic value about 28% below the current price and an overall score of 4.2 out of 5 (strong company).
UNITED THERAPEUTICS Corp (UTHR): It has revenue growth of 18% a year over three years, an average net margin of 42%, a P/E of about 22, an intrinsic value about 45% below the current price and an overall score of 4.0 out of 5 (strong company).
Frequently asked questions
What is the best healthcare stock right now?
By today’s analysis score, Exelixis, Inc. (EXEL) leads the sector with 4.4 out of 5. A score is one measure and does not replace a full analysis.
How is the 0–5 score calculated?
Each stock faces five numeric tests in each of five areas (value, future, past, financial health and shareholder returns); the overall score is the average of the five.
How many healthcare stocks are listed in the US?
Our data covers 971 healthcare stocks, each with its own analysis page.
More lists and tools
Lists are generated automatically from SEC filings and market prices and rebuilt every day. They are a starting point for research, not a recommendation to buy or sell.